None. Conflicts of Interest: Good News! NEJM 2011
|
|
- Cathleen Hamilton
- 5 years ago
- Views:
Transcription
1 Napa Dermatoathology Meeting 2018: Medicolegal Issues in Dermpath Whitney A. High, MD, JD, MEng Professor of Dermatology & Pathology Vice-Chairman, Dermatology Director of Dermatopathology Director of Adult Dermatology Clinic University of Colorado School of Medicine May 18, 2018 Napa, CA Conflicts of Interest: None I am a practicing dermatologist/dermatopathologist. I hold a law degree. I do not practice law. This lecture is not legal advice. Good News! NEJM 2011 Examined claims: 40,000 docs 6 year period overall 7.4%/year were sued medical specialty 55% sued by 65 y/o surgical specialty 74% sued by 45 y/o Jena et al. N Engl J Med 2011; 365:
2 January 26, 2016 Approximately 1% of all physicians accounted for 32% of paid claims Laser accidents 2 Cosmetic filler 1 Isotretinoin complications 3 Missed melanoma 6 Chloroquine 1 TEN/SJS 1 NMSC 1 Potent steroids 2 Light therapy 1 Connective tissue disease 1 Cryosurgery 1 Merkel cell 1 Balanitis obliterans with SCC 1 Litigation In Derm & Dermpath Misdiagnosis of melanoma and skin cancer = major risk points Pathology Claims The Doctors Company : skin cancer and/or melanoma 8.6% of all claims against pathologists 14.2% of all claims against dermatologists : melanoma #1 specific claim (7/yr) 95% false negative, 5% false positive : melanoma #1 specific claim (2/yr) 96% false negative, 6% false positive Troxel et al. Am J Surg Pathol 2012;36:e1 e5 2
3 Purpose of Malpractice Law To identify a party injured because of substandard care and compensate the party, so as to make them whole. Malpractice is tort law Controlled by state law It is a civil action Preponderance of the evidence (>50%) Elements of Malpractice Six elements of a prima facie case 1. Duty 2. Standard of Care 3. Breach of Duty 4. Cause in Fact 5. Proximate Cause (Legal Cause) 6. Damages (failure to prove a single element is fatal) Causation Simple Pyramidal Structure Duty To Act Negligent Action or Inaction Damage$ from Negligent Action/Inaction 3
4 Standard of Care Some states: reasonably prudent physician of same background, training, experience Other states: knowledge and skill common to members in good standing Notes The outcome does NOT have to be favorable! You do NOT have to be correct! STANDARD OF CARE IS ESTABLISHED DE NOVO IN EVERY CASE Attorneys Not Interested in Close Calls Average cost of lawsuit Plaintiff s Atty. = $ k Where s Waldo cases some pigmented lesions are difficult for ALL experts Farmer, et al. (1996) 37 classic pigmented lesions, 8 expert dermpaths only 1/3 of cases with complete agreement Chilling not only to physicians, but to patients, and sobering to lawyers for plaintiffs. - A.B. Ackerman,
5 The Doctor s Defense Attack validity of the required elements there was not duty there was no breach the standard of care there are no damages Assert an affirmative defense 1. Conflicting legal duty (psychiatrists) 2. Consent (most often employed defense for procedures) 3. Statute of Limitations (variable length) Statute of Limitations Time period when a suit must be filed Varies from state-to-state Tolled in children until a certain age age of majority, simply a specified age Point of argument in many situations: begins when one is reasonably alerted to an injury and not simply date of service Anonymous Pt v. Anonymous Derm Virginia 1997 Plaintiff sought care for mole upon leg Derm biopsied interpreted as benign Two years later pt. visited a surgeon Surgeon requested medical records Derm then re-assessed slide and amended the pathology report melanoma Was suit timely? 5
6 COMPENSATORY DAMAGES Court Decision SOL did not begin at misdiagnosis RULING: SOL began 2 years from when melanoma moved into the dermis (When the heck was that?) Important point: SOL begins when injured party should have been reasonably aware that an injury had transpired (and it is a point that may be argued). Show Me the Money! Special damages medical bills (past, present, future) lost wages (past, present, future) General damages pain & suffering (per diem vs. lump sum) loss of enjoyment/consortium RARELY PUNITIVE DAMAGES! There are few lawsuits. True Harvard study 1/25 persons harmed by medical error 2006 Harvard f/u study 1/25 of those harmed (1/625) brought litigation 6
7 Ten Suggestions To Reduce Medicolegal Risk Associated with Pigmented Lesions I. Beware of Partial Capture Cutis, Nov Number of shaves increased Volume of shaves decreased This impacts the accuracy of diagnosis 7
8 Always punch the thickest area Pariser et al. DOJ 1999; 5(2):4 R/O angioma 8
9 The patient Different clinicians may not always appreciate the randomness of pathology. It is important that we educate our clients rather than merely appease. 4 mm Punch Biopsy by Volume - Assume 4 mm cylinder Volume of punch is = 50.3 mm 3 - Assume is two 3.5 um silhouettes on slide Volume inspected is = mm 3 The dermatopathologist is inspecting 1/450th of the overall volume of the sampling!!!! 9
10 5 cm Excision by Perimeter Analysis - Assume excision is 1:3.5 ratio (common) Circumference is = cm - Assume grossed into 7 pieces each 3.5 um thick Circumference inspected is = cm The dermatopathologist is inspecting just 1/2300th of the overall circumference of the excision!!!! Residual XYZ, completely excised. vs. Residual XYZ, margins uninvolved. vs. Residual XYZ, margins uninvolved in these planes of section. But trial attorneys are increasingly aware and can find data quickly! 10
11 II. Beware of Inflamed Lesions (which could be hiding malignancy) Case 79 year-old man Pigmented lesion on chest r/o NUB Old Adage: Lymphocytes recognize malignancy better than do pathologists! Histology 11
12 Case 79 year-old man Pigmented lesion on chest r/o NUB Old Adage: Lymphocytes recognize melanoma better than do pathologists! III. Beware of spitzoid lesions 12
13 Difficulty of Spitz nevus vs spitzoid melanoma ( All or Nothing ) Features that may suggest more strongly spitzoid melanoma: Age > 20 years Predominantly epithelioid cells Larger lesions (> 0.6 to 1.0 cm) Lesions on sun-damaged skin Lesion with multiple morphologies (new exception = BAPomas ) Adopted from Troxel DB, AM J Surg Pathol 2003; 22: Classic Spitz Nevus Spitzoid Melanoma 63 year-old man VA patient in Wyoming Agree this is a Spitz nevus. 13
14 IV. Beware of Regression Better the Devil you know than the Devil you don t know. - Old English Proverb Case June 2004 Sent by barber for lesion upon scalp Biopsy performed interpreted by dermatologist as blue nevus 14
15 Histology of Original Biopsy September 2006 Paradox - As treatments for melanoma improve, so to do the consequences (and damages) for missing melanoma at all stages of disease. 15
16 V. Beware of Desmoplastic Melanoma and Other Spindle-Cell Lesions You just ain t gonna think of it, if it doesn t enter your mind. Yogi Berra - Me Desmoplastic Melanoma 16
17 Recent DF From Idaho Factor XIIIa 17
18 PanCK CK 8/18 P63 CONCLUSION: NOT a DF at all Poorly differentiated SCC Spindled neoplasms require more than one screening stain! VI. Always Look at All the Sections on a Slide Ginsu-ed specimen 18
19 Always Look at All the Sections 19
20 VII. Work as a Team with the Clinician Prevent An Error Before It Transpires Teach simple mantra of Crap in = Crap out r/o melanoma on every specimen r/o cancer on every specimen rash or D48.5 for everything Discourage multiple specimens in same bottle Discourage curetting of a pigmented lesion Note mismarking shaves, punches, excisions Not new ideas. I promote doing biopsies in 3D : - Description - Diameter or Distribution - Diagnosis 20
21 It should be our expectation that any information that might impact the overall analysis is never withheld. Know your clientele. - training varies -experience varies -thresholds vary -practice dynamics vary 21
22 I don t have to worry too much about who reads my path if an error happens, it s on them. VIII. Do no harm! Don t cost someone else their skin just to save your own. 22
23 The Phenomenon As a response to medicolegal pressure two responses: Becoming malignant Fence sitting or hedging Neither improves patient care Both contribute to increased costs IX. Acknowledge Difficult Cases It was pride that changed angels into devils; it is humility that makes men as angels. - Saint Augustine Humility Is Not Just Good for Your Character Acknowledge differences in opinion: This is a difficult case The type of case for which reasonable opinions may vary At present, some pigmented lesions are classifiable only with benefit of hindsight With benefit of this larger sampling and clinical data Consensus Conference 23
24 X. Encourage Open Lines of Communication Tincture of Follow Up This is MELANOMA. If any other diagnosis returns from the dermatopathologist, it should be treated with great suspicion. Ultimately, the diagnosis was ALMM 1.6 mm deep. 24
25 Thank you 25
Whitney A. High, MD, JD, MEng
AOCD Annual Meeting 2016 Medicolegal Issues in Dermatology & Dermpath Whitney A. High, MD, JD, MEng Associate Professor, Dermatology & Pathology Director of Dermatopathology (Dermatology) University of
More informationDavid B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma
Common Medicolegal Situations: Misdiagnosis of Melanoma David B. Troxel, MD Medical Director, The Doctors Company, Napa, California Clinical Professor Emeritus, University of California at Berkeley Past
More informationThere is NO single Melanoma Stain. > 6000 Mutations in Melanoma. What else can be done to discriminate atypical nevi from melanoma?
Las Vegas Fall Clinical 2016: The Assessment and Diagnosis of Melanoma Whitney A. High, MD, JD, MEng Associate Professor, Dermatology & Pathology Director of Dermatopathology (Dermatology) University of
More informationA PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL
A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL OBJECTIVES Discuss current trends and changing concepts in our understanding of
More informationSTATE OF MINNESOTA IN SUPREME COURT. A Court of Appeals Gildea, J. Took no part, Magnuson, C.J.
STATE OF MINNESOTA IN SUPREME COURT A06-1982 Court of Appeals Gildea, J. Took no part, Magnuson, C.J. Margaret MacRae, trustee for the next of kin of Roderick MacRae, Appellant, vs. Filed: July 31, 2008
More informationVernon K. Sondak. Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida
Vernon K. Sondak Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida Australasian Melanoma Conference 2016 Sydney, NSW, Australia October 29, 2016 Disclosures Dr. Sondak is a compensated
More informationAssociate Clinical Professor of Dermatology MUSC
Re-excision of Moderately Dysplastic Nevi: Should we or shouldn t we? John C. Maize, Jr, M.D. Dermatologist and Dermatopathologist Trident Dermatology, Charleston SC Associate Clinical Professor of Dermatology
More informationTAXOTERE: WHAT YOU NEED TO KNOW ABOUT IT
TAXOTERE: WHAT YOU NEED TO KNOW ABOUT IT 1 Fighting breast cancer is a very emotional battle for women. Doctors are trying to save the lives of women by trying new and innovative methods and drugs. One
More informationPacific NW Derm 83 rd Conference 7/16/16 Medical Legal Concerns for a Dermatopathologist, c Jane M. Grant-Kels, M.D., FAAD Professor of
Pacific NW Derm 83 rd Conference 7/16/16 Medical Legal Concerns for a Dermatopathologist, c. 2016 Jane M. Grant-Kels, M.D., FAAD Professor of Dermatology, Pathology & Pediatrics Director of Cutaneous Oncology
More informationTracking skin cancers and melanoma at the microscopic level
Tracking skin cancers and melanoma at the microscopic level Rosalie Elenitsas, M.D. Professor of Dermatology Director of Dermatopathology Hospital of the University of Pennsylvania May 12, 2017 Outline
More informationHistotechnological problems in dermatopathology and their possible consequences
Histotechnological problems in dermatopathology and their possible consequences Zsolt B. Argenyi, M.D. Professor of Pathology & Dermatology Director of Dermatopathology University of Washington, Seattle,
More informationProtocol applies to melanoma of cutaneous surfaces only.
Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Procedures Biopsy (No Accompanying Checklist) Excision Re-excision Protocol revision date: January 2005 Based on AJCC/UICC
More informationManagement of Atypical Pigmented Lesions
Management of Atypical Pigmented Lesions Jennifer A. Stein MD, PhD Associate Director, Pigmented Lesion Section Ronald O. Perelman Department of Dermatology NYU Langone Medical Center July 29, 2017 1-4
More informationStatute: Liability for Failure to Vaccinate
Statute: Liability for Failure to Vaccinate Proposal: Create a statute that would hold a parent who decides, without a valid medical reason, to not vaccinate his or her child according to the State s school
More informationMelanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU
Melanoma Underwriting Presented at 2018 AHOU Conference Hank George FALU MELANOMA EPIDEMIOLOGY 70-80,000 American cases annually Majority are in situ or thin > 20% are diagnosed age 45 8-9,000 melanoma
More informationDermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial
Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial Cutaneous Oncology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI
More informationRESULT OF SURVEY OF 1705 LAWSUITS* ORAL CANER: A significant Public Health Concern. ORAL CANCER: Other Epidemiologic Facts
FAILURE TO DIAGNOSE ORAL CANCER AND OTHER PATHOLOGIC CONDITIONS OF THE ORAL CAVITY Kalu U.E. Ogbureke, BDS, MSc, DMSc, JD, FDSRCS, FDSRCPS, FDSRCSEd, FRCPath Diplomate, American Board of Oral and Maxillofacial
More informationFor additional information on meeting the criteria for Mohs, see Appendix 2.
Position Statement on Appropriate Uses of Paraffin Sections in Association (Approved by the Board of Directors: August 1, 2011; Revised November 5, 2011; Revised August 9, 2014) According to AMA/CPT, Mohs
More informationIf you sought health insurance coverage or benefits from MAGNETIC STIMULATION ( TMS )
LEGAL NOTICE BY ORDER OF THE UNITED STATES DISTRICT COURT FOR THE CENTRAL DISTRICT OF CALIFORNIA If you sought health insurance coverage or benefits from CIGNA HEALTH AND LIFE INSURANCE CO. for TRANSCRANIAL
More informationClinicopathologic Self- Assessment S003 AAD 2017
Clinicopathologic Self- Assessment S003 AAD 2017 Clay J. Cockerell, M.D. Director, Cockerell Dermatopathology Director, Division of Dermatopathology UT Southwestern Medical Center July 2017 No relevant
More informationKING COUNTY SUPERIOR COURT, WASHINGTON STATE CAUSE NO SEA
KING COUNTY SUPERIOR COURT, WASHINGTON STATE CAUSE NO. 11-2-34187-9 SEA ATTENTION: CURRENT AND PRIOR REGENCE BLUESHIELD INSUREDS WHO CURRENTLY REQUIRE, OR HAVE REQUIRED IN THE PAST, SPEECH, OCCUPATIONAL
More informationViral Infections. Chicken Pox 5/21/2018
Napa Valley Dermatopathology Meeting 2018 - Select Infections & Infestations Whitney A. High, MD, JD, MEng whitney.high@ucdenver.edu Professor of Dermatology & Pathology Vice-Chairman, Dermatology Director
More informationMelanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media
Melanoma and Dermoscopy Richard P. Usatine, MD, FAAFP Professor, Family and Community Medicine Professor, Dermatology and Cutaneous Surgery Medical Director, University Skin Clinic University of Texas
More informationQuality, Patient Safety and Error Reduction in Cytopathology
CAP Companion Society Meeting at USCAP 2009 Quality Assurance, Error Reduction, and Patient Safety in Anatomic Pathology Quality, Patient Safety and Error Reduction in Cytopathology Jan F. Silverman, MD,
More informationDermatology Procedure Coding
Dermatology Procedure Coding Anatomy Two layers that make up human skin Epidermis most superficial layer Composed of four to five layers called stratum Anyone remember the mnemonic? Thickness varies based
More informationConfidence in Sampling: Why Every Lawyer Needs to Know the Number 384. By John G. McCabe, M.A. and Justin C. Mary
Confidence in Sampling: Why Every Lawyer Needs to Know the Number 384 By John G. McCabe, M.A. and Justin C. Mary Both John (john.mccabe.555@gmail.com) and Justin (justin.mary@cgu.edu.) are in Ph.D. programs
More informationDermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia
Dermatopathology Dr. Rafael Botella Estrada. Hospital La Fe de Valencia Melanoma and mimics Dr. Martin Mihm Malignant lesions result from the accumulation of mutations Class I lesions (benign) Class II
More informationLichenoid Tissue Reaction in Malignant Melanoma A Potential Diagnostic Pitfall
natomic Pathology / LICHENOID TISSUE RECTION IN MLIGNNT MELNOM Lichenoid Tissue Reaction in Malignant Melanoma Potential Diagnostic Pitfall CPT Scott R. Dalton, MC, US, 1,3 Capt Matt. aptista, USF, MC,
More informationUse of Supporting Evidence With the IME Physician at Trial
Use of Supporting Evidence With the IME Physician at Trial By Ben Rubinowitz and Evan Torgan In most personal injury lawsuits, the defendant has the right to have the plaintiff submit to a physical exam
More informationII. The Federal Government s Current Approach to Compensation. The issue of compensation for vaccine related injuries has been brought to
13 II. The Federal Government s Current Approach to Compensation The issue of compensation for vaccine related injuries has been brought to congressional and wider public attention most dramatically in
More informationState of Connecticut Department of Education Division of Teaching and Learning Programs and Services Bureau of Special Education
State of Connecticut Department of Education Division of Teaching and Learning Programs and Services Bureau of Special Education Introduction Steps to Protect a Child s Right to Special Education: Procedural
More informationThe Enigmatic Spitz Lesion
The Enigmatic Spitz Lesion The Dawn of Spitz S Spitz Sophie Spitz Melanomas of Childhood ; Am J Pathol 1948 1910-1956 13 children (18 mo - 12 yrs) 12/13 had a benign clinical course Sophie Spitz Born 1910
More informationWays to get into trouble, ideas on avoiding trouble, and diagnostic approaches to keep trouble at bay
Pitfalls in the diagnosis of melanocytic tumors Timothy McCalmont, MD University of California, San Francisco Ways to get into trouble, ideas on avoiding trouble, and diagnostic approaches to keep trouble
More informationSTATE OF LOUISIANA COURT OF APPEAL, THIRD CIRCUIT **********
STATE OF LOUISIANA COURT OF APPEAL, THIRD CIRCUIT 07-1205 CHANDA HESTER VERSUS JOHN T. NING, M.D., ET AL. ********** APPEAL FROM THE THIRTIETH JUDICIAL DISTRICT COURT PARISH OF VERNON, NO. 74,052, DIV.
More informationGuide to Selecting Legal Representation for Brain Injury Cases
Guide to Selecting Legal Representation for Brain Injury Cases An attorney can investigate the case, determine what kind of case to bring against which defendant, and begin preparing the case while the
More informationThe Optical Biopsy. Douglas S. Scherr
Patricia Kuharic 66 The Optical Biopsy Douglas S. Scherr UROLOGY, WEILL CORNELL MEDICAL COLLEGE We want to create a better way to look inside the walls of a bladder for cancerous cells, eliminating the
More informationMesothelioma and the Law:
Mesothelioma and the Law: Things Doctors Need to Know Presented by Steven Kazan Managing Partner Kazan, McClain, Abrams, Lyons, Greenwood & Harley, PLC I. The Cause of Mesothelioma is Asbestos The Cause
More information6/22/2015. Original Paradigm. Correlating Histology and Molecular Findings in Melanocytic Neoplasms
6 Correlating Histology and Molecular Findings in Melanocytic Neoplasms Pedram Gerami MD, Associate Professor of Dermatology and Pediatrics at Northwestern University Disclosures: I have been a consultant
More informationDermatopathology Training Standards
Dermatopathology Training Standards Tammie Ferringer, MD Section Head and Fellowship Director Dermatopathology Depts of Dermatology and Pathology tferringer@geisinger.edu I do not have any relevant relationships
More informationDesmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC
R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o
More informationMole mapping and monitoring. Dr Stephen Hayes. Associate Specialist in Dermatology, University Hospital Southampton
Mole mapping and monitoring Dr Stephen Hayes Associate Specialist in Dermatology, University Hospital Southampton Outline of presentation The melanoma epidemic Benefits of early detection Risks of the
More informationApplying Risk Management Principles to QA in Surgical Pathology: From Principles to Practice
Applying Risk Management Principles to QA in Surgical Pathology: From Principles to Practice Dr. Gregory Flynn CEO, Institute for Quality Management in Healthcare Managing Director, Quality Management
More informationElectroconvulsive Treatment (ECT)
California s Protection & Advocacy System Toll-Free (800) 776-5746 Electroconvulsive Treatment (ECT) October 2002, Pub #5398.01 The purpose of this brochure is to tell you about your legal rights regarding
More informationWhitney A. High, MD, JD, MEng
ADS Dermatopathology Meeting 2014 Selected Adnexal Tumors Whitney A. High, MD, JD, MEng Associate Professor, Dermatology & Pathology Director of Dermatopathology (Dermatology) University of Colorado School
More informationAdvances in Surgical Management of Primary Melanoma: Identifying Patients Who Need More than Conventional Wide Local Excision
Advances in Surgical Management of Primary Melanoma: Identifying Patients Who Need More than Conventional Wide Local Excision Christopher J. Miller, MD Director of Penn Dermatology Oncology Center Associate
More informationMelanocytic proliferations in sundamaged
Atypical Spitzoid Tumor: What Does It Mean And How Should It Be Managed? Melanocytic proliferations in sundamaged skin Jane L. Messina, Jane L. Messina MD International Melanoma Pathology Working Group
More informationUpdate on Cutaneous Mesenchymal Tumors. Thomas Brenn
Update on Cutaneous Mesenchymal Tumors Thomas Brenn Cutaneous Mesenchymal Tumours Wide morphological and biological spectrum Myofibroblastic, smooth muscle, neural, vascular, apidocytic, undifferentiated;
More informationSKIN CANCER SCREENING AT UPMC. Laura K. Ferris, MD, PhD Associate Professor of Dermatology
SKIN CANCER SCREENING AT UPMC Laura K. Ferris, MD, PhD Associate Professor of Dermatology UPMC Largest health care system in Western PA 21+ hospitals with >5,100 licensed beds More than 500 outpatient
More informationAlcohol should be avoided for 3 days prior to surgery and 2 days after the procedure.
Mohs Surgery Information Packet Be sure to bring the following to your appointment: Insurance Card Insurance Referral ( If required by your insurance) Name and address of your primary care provider as
More informationMelanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018
Melanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018 Victor G. Prieto, MD, PhD Professor Depts. of Pathology and Dermatology University of Texas - MD Anderson Cancer Center
More informationA Review of Medical Malpractice Claims from the CRICO Comparative Benchmarking System
A Review of Medical Malpractice Claims from the CRICO Comparative Benchmarking System (CBS: a national database of medical malpractice claims from captive & commercial insurers across the US ) Note: I
More informationI have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee
I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee Some thoughts Is this skin cancer? How common is this? How likely is this in this patient? What happens next if it s something
More informationPrimary Care Dermatology Coding. Webinar Subscription Access Expires December 31.
Primary Care Dermatology Coding Questions Answers Webinar Subscription Access Expires December 31. How long can I access the on demand version? You will find that in the same instructions box you utilized
More informationTips on getting the most from your alopecia pathology reports. D irector, H a ir C linic, Boston Medical C e n ter
Tips on getting the most from your alopecia pathology reports Lynne J. Goldberg, MD J a g Bhawan Professor o f Dermatology a n d Pathology & Laboratory Medicine Boston U n iversity School of Medicine D
More informationCancer Reporting for Dermatologists. Florida Department of Health Florida Cancer Data System. March 9, Agenda
Cancer Reporting for Dermatologists Florida Department of Health Florida Cancer Data System March 9, 2011 Agenda Welcome Introductions Cancer Reporting in Florida BETA Participation Expectations Review
More informationLentigo Maligna: Striking a Balance With the Risk-Benefit Ratio. Glen M. Bowen, MD Huntsman Cancer Institute University of Utah
Lentigo Maligna: Striking a Balance With the Risk-Benefit Ratio Glen M. Bowen, MD Huntsman Cancer Institute University of Utah I. Objectives: a. Review the terminology of LM/LMM b. Understand the relative
More informationToby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma
Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980:
More information1. A(n) is someone who has education, profession or specialized experience that qualifies him or her with great knowledge of a certain subject.
EXAM: Chapters 4-5 Name: Date: 1. A(n) is someone who has education, profession or specialized experience that qualifies him or her with great knowledge of a certain subject. 2. In order for someone to
More informationToby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma
Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980:
More informationSHARED DECISION MAKING FOR PROSTATE CANCER SCREENING
SHARED DECISION MAKING FOR PROSTATE CANCER SCREENING 16 TH A N N U A L M A S S A C H U S E T T S P R O S T A T E C A N C E R S Y M P O S I U M Mary McNaughton-Collins, MD, MPH Foundation Medical Director
More informationBy now you re probably sick of the relentless attack of the alien melanocytes DAILY in your practice. Melanocytic conundrums
Melanocytic conundrums Ron Rapini MD, Chernosky Chair, Dept Derm Professor of Pathology Univ Texas Medical School at Houston MD Anderson Cancer Center Conflict of interest statement: None - I have no stock
More informationSkin Malignancies. Presented by Dr. Douglas Paauw
Skin Malignancies Presented by Dr. Douglas Paauw Disclosure: Dr. Paauw has no significant financial interest in any of the products or manufacturers mentioned. How Common Is Skin Cancer? *½ of all White
More informationProposal for a 2-stage RCT in high risk primary SCC: COMMISSAR Catherine Harwood Barts Health NHS Trust / QMUL
Proposal for a 2-stage RCT in high risk primary SCC: COMMISSAR Catherine Harwood Barts Health NHS Trust / QMUL on behalf of Dr Louise Lansbury, Prof Fiona Bath-Hextall Nottingham Centre for Evidence Based
More informationMoh's Surgery Information Packet
Moh's Surgery Information Packet BE SURE TO BRING THE FOLLOWING TO YOUR APPOINTMENT Insurance card Insurance referral (if required by your insurance) Name and address of your primary care provider as well
More informationVACAVILLE DERMATOLOGY
Connecting the Dots on those Spots NANDAN V. KAMATH, M.D. VACAVILLE DERMATOLOGY Sources All of the photos were taken with permission from the Dermnet NZ website - Dermnet New Zealand after communicating
More informationSchool Mental Health and the Expert Witness A Primer for Mental Health and Education Professionals
School Mental Health and the Expert Witness A Primer for Mental Health and Education Professionals 2018 CSMH Conference William Dikel, MD Independent Consulting Child and Adolescent Psychiatrist 612 275-7385
More informationUveal Melanoma. Protocol applies to malignant melanoma of the uvea.
Uveal Melanoma Protocol applies to malignant melanoma of the uvea. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition Procedures Cytology (No Accompanying Checklist) Biopsy (No Accompanying
More informationCancer of the Oral Cavity
The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology Cancer of the Oral Cavity Ashok Shaha Principals of Management of Oral Cancer A)
More information> 6000 Mutations in Melanoma. Tests That Cay Be Employed. FISH for Additions/Deletions. Comparative Genomic Hybridization
Winter Clinical 2017: The Assessment and Diagnosis of Melanoma Whitney A. High, MD, JD, MEng Associate Professor, Dermatology & Pathology Director of Dermatopathology (Dermatology) University of Colorado
More informationPFAS -- SO? What s the PROBLEM? Kenneth F. Gray, Esq. LSPA Course November 29, 2017 Taunton, MA
PFAS -- SO? What s the PROBLEM? Kenneth F. Gray, Esq. LSPA Course November 29, 2017 Taunton, MA Per- and Polyfluoroalkyl Substances (PFAS) Just another emerging contaminant? Or another PCB or asbestos?
More informationMalignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha
Malignant tumors of melanocytes : Part 3 Deba P Sarma, MD., Omaha Let s go over one case of melanoma using the following worksheet. Of the various essential information that needs to be included in the
More informationv. Record No OPINION BY JUSTICE CYNTHIA D. KINSER January 8, 1999 ELAINE R. WEBB FROM THE COURT OF APPEALS OF VIRGINIA
Present: All the Justices A NEW LEAF, INC., ET AL. v. Record No. 980454 OPINION BY JUSTICE CYNTHIA D. KINSER January 8, 1999 ELAINE R. WEBB FROM THE COURT OF APPEALS OF VIRGINIA In this appeal, we decide
More informationUnderstanding Erb's Palsy
Understanding Erb's Palsy Erb s palsy, also known as brachial palsy, is a serious injury that occurs when a baby s shoulder nerves called the brachial plexus are damaged during delivery. Erb s palsy occurs
More informationMalignant tumors of melanocytes: Part 1. Deba P Sarma, MD., Omaha
Malignant tumors of melanocytes: Part 1 Deba P Sarma, MD., Omaha The melanocytic tumor is one of the most difficult and confusing areas in Dematopathology. It is true that most (95%) of such lesions are
More informationDestruction or Excision: What's Happening in Your Dermatology Office?
Questions Destruction or Excision: What's Happening in Your Dermatology Office? Answers Webinar Subscription Access Expires December 31. Doc excises a "pendunculated gluteal mass" with a fullthickness
More informationv. Record No OPINION BY JUSTICE BARBARA MILANO KEENAN June 7, 1996 ANN B. SOWERS, M.D., ET AL.
Present: All the Justices JASON KING, AN INFANT, ETC. v. Record No. 951688 OPINION BY JUSTICE BARBARA MILANO KEENAN June 7, 1996 ANN B. SOWERS, M.D., ET AL. FROM THE CIRCUIT COURT OF THE CITY OF ROANOKE
More informationSpecialists in asbestos litigation
Specialists in asbestos litigation Patient information fact sheet about: Asbestos Compensation Claims Your guide and information pack to explain what financial help is available for those suffering from
More informationDr Claire McIvor University of Birmingham
The misuse of statistical evidence in UK tort law: basic mistakes made by the court when assessing epidemiological evidence to determine questions of factual causation in complicated disease litigation
More informationFAQ FOR THE NATA AND APTA JOINT STATEMENT ON COOPERATION: AN INTERPRETATION OF THE STATEMENT September 24, 2009
FAQ FOR THE NATA AND APTA JOINT STATEMENT ON COOPERATION: AN INTERPRETATION OF THE STATEMENT September 24, 2009 Introduction The NATA considers the Joint Statement on Cooperation a very positive resolution
More informationperpetuate -- and perhaps even intensify -- that controversy. 1 On July 18th, the Fifth Circuit affirmed FDA s longstanding position that
Food & Drug July 29, 2008 Fifth Circuit Rules that FDA May Regulate Compounded Drugs as New Drugs Update on Medical Center Pharmacy v. Mukasey For decades, the pharmacy compounding industry has disputed
More informationSkin Cut Up D R R O K I A H A L I C O N S U L T A N T D E R M A T O P A T H O L O G I S T S T H
Skin Cut Up D R R O K I A H A L I C O N S U L T A N T D E R M A T O P A T H O L O G I S T S T H General Instructions 5.1.1 The type of biopsy is documented. 5.1.2 Orientated or not (suture indicating what
More informationPsychological Injury and Law: Editorial on Practice Criteria
Psychol. Inj. and Law (2009) 2:4 9 DOI 10.1007/s12207-009-9035-6 EDITORIAL Psychological Injury and Law: Editorial on Practice Criteria Gerald Young Received: 20 December 2008 / Accepted: 16 January 2009
More informationPolicy #: 127 Latest Review Date: June 2011
Name of Policy: Mohs Micrographic Surgery Policy #: 127 Latest Review Date: June 2011 Category: Surgery Policy Grade: Active Policy but no longer scheduled for regular literature reviews and updates. Background/Definitions:
More informationWhen in doubt, ask an expert
When in doubt, ask an expert MARC BEISHON No pathologist can be an expert in every type of cancer. But there is a lot that can be done to greatly improve the accuracy of diagnoses, particularly in rare
More informationWhat is melanoma? Melanoma dealing with the diagnosis. What is melanoma?
Melanoma is a form of cancer which develops from that part of the skin which produces its colour. It grows from the cell which produces the brown pigment in our skin: the melanocyte. Often the melanoma
More informationBEFORE THE ARKANSAS WORKERS COMPENSATION COMMISSION CLAIM NO. F OPINION FILED JULY 21, 2006
BEFORE THE ARKANSAS WORKERS COMPENSATION COMMISSION CLAIM NO. F512053 DONNA ERBACH, EMPLOYEE UNIVERSITY OF CENTRAL ARKANSAS, EMPLOYER PUBLIC EMPLOYEE CLAIMS DIVISION, INSURANCE CARRIER CLAIMANT RESPONDENT
More informationPlease take time to read this document carefully. It forms part of the agreement between you and your counsellor and Insight Counselling.
Informed Consent Please take time to read this document carefully. It forms part of the agreement between you and your counsellor and Insight Counselling. AGREEMENT FOR COUNSELLING SERVICES CONDUCTED BY
More informationDECISION NO. 788/91. Suitable employment; Medical restrictions (repetitive bending and lifting).
DECISION NO. 788/91 Suitable employment; Medical restrictions (repetitive bending and lifting). The worker suffered three compensable back injuries between April 1982 and August 1983. He appealed the denial
More informationDiagnostics guidance Published: 11 November 2015 nice.org.uk/guidance/dg19
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions Diagnostics guidance Published: 11 November 2015 nice.org.uk/guidance/dg19 NICE 2018. All rights reserved. Subject to Notice of
More informationCOMMUNITY HOSPICE & PALLIATIVE CARE NOTICE OF PRIVACY PRACTICES
COMMUNITY HOSPICE & PALLIATIVE CARE NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE
More informationSkin lesions The Good and the Bad. Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry
Skin lesions The Good and the Bad Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry Case 1 32 year old woman Australian Lesion on back New hair growing
More informationBEFORE THE ARKANSAS WORKERS' COMPENSATION COMMISSION CLAIM NO. G JANNIE A. HYMES, EMPLOYEE PINEWOOD HEALTH & REHABILITATION, EMPLOYER
BEFORE THE ARKANSAS WORKERS' COMPENSATION COMMISSION CLAIM NO. G202747 JANNIE A. HYMES, EMPLOYEE PINEWOOD HEALTH & REHABILITATION, EMPLOYER HARTFORD UNDERWRITERS INSURANCE COMPANY, INSURANCE CARRIER CLAIMANT
More informationExhibit 2 RFQ Engagement Letter
Exhibit 2 RFQ 17-25 Engagement Letter The attached includes the 6 page proposed engagement letter to be used by HCC. ENGAGEMENT LETTER Dear: [Lead Counsel/Partner] We are pleased to inform you that your
More informationRCGP and Cancer Research UK Workshop. Hilton Newcastle Gateshead, Bottle Bank, Gateshead, NE8 2AR 13 th July 2017
Hilton Newcastle Gateshead, Bottle Bank, Gateshead, NE8 2AR 13 th July 2017 Dr Richard Roope RCGP and Cancer Research UK Cancer Clinical Champion Senior Clinical Advisor Cancer Research UK How can GPs
More informationBEFORE THE ARKANSAS WORKERS COMPENSATION COMMISSION CLAIM F ROBERT LEON PAVEL, EMPLOYEE CLAIMANT
BEFORE THE ARKANSAS WORKERS COMPENSATION COMMISSION CLAIM F308513 ROBERT LEON PAVEL, EMPLOYEE CLAIMANT UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES, EMPLOYER RESPONDENT ARKANSAS INSURANCE DEPARTMENT, PUBLIC
More informationa) From initial interview, what does the client want? g) Formulate a timetable for action List options to present to client.
From: Legal Services Practice Manual: Skills 2017 Benchmark Institute CASE PLANNING GUIDE 1. IDENTIFY CLIENT OBJECTIVES a) From initial interview, what does the client want? b) Summarize facts c) Identify
More informationMesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016
Mesothelioma: diagnostic challenges from a pathological perspective Naseema Vorajee August 2016 Naseema.vorajee@nhls.ac.za Pleural diseases (whether neoplastic, reactive or infective) may have similar
More informationGrant Application for Individuals
Grant Application for Individuals Thank you for your interest in applying for a grant from Small Steps in Speech, a nonprofit 501(c)3 foundation created in memory of Staff Sgt. Marc J. Small. The Board
More information